Xeris Biopharma Holdings (XERS) Return on Sales (2020 - 2026)
Xeris Biopharma Holdings' (XERS) quarterly Return on Sales came in at 0.0% in Q1 2026, little changed YoY from 0.0% in Q1 2025, and down 79.19% on a QoQ basis from 0.0% in Q4 2025.
Xeris Biopharma Holdings (XERS) Return on Sales (2020 - 2026) Analysis & Trends
Xeris Biopharma Holdings (XERS) has 7 years of Return on Sales data on file, last reported at 0.0% in Q1 2026.
- Quarterly Return on Sales changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
- Return on Sales declined to 0.0% in Q1 2026, from 0.0% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.0% in Q4 2025 to a low of 0.02% in Q1 2022.
- A 5-year average of 0.0% and a median of 0.0% in 2023 frame the typical range for Return on Sales.
- Annual changes were most pronounced in 2022 — Return on Sales gained 2 bps — and 2023, when it changed 0 bps.
- Tracing XERS's Return on Sales over 5 years: stood at 0.0% in 2022, then climbed by 23 bps to 0.0% in 2023, then jumped by 72 bps to 0.0% in 2024, then jumped by 252 bps to 0.0% in 2025, then slumped by 79 bps to 0.0% in 2026.
- The last three Return on Sales figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 0.00% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 0.00% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.00% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 0.00% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 0.00% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.00% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Xeris Biopharma Holdings | 1.48 Bn | 1.36 Bn | 79.59 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00% |
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.02% |
| Dec 31, 2021 | -0.02% |
| Sep 30, 2021 | -0.02% |